Mass spectrometric proteomics profiles of in vivo tumor secretomes: capillary ultrafiltration sampling of regressive tumor masses.
about
Approaches to the study of the cell secretomeIn vivo sampling of extracellular beta-thymosin by ultrafiltration probes.Salivary proteomics for oral cancer biomarker discoveryPlasma Protein Biomarkers Correlated with the Development of Diet-Induced Type 2 Diabetes in Mice.S137 phosphorylation of profilin 1 is an important signaling event in breast cancer progression.Interstitial fluid: the overlooked component of the tumor microenvironment?Breast tumor microenvironment: proteomics highlights the treatments targeting secretome.Proteomics integrated with Escherichia coli vector-based vaccines and antigen microarrays reveals the immunogenicity of a surface sialidase-like protein of Propionibacterium acnes.Tumor Interstitial Fluid Formation, Characterization, and Clinical ImplicationsProfilin 1 is a potential biomarker for bladder cancer aggressivenessSampling human indigenous saliva peptidome using a lollipop-like ultrafiltration probe: simplify and enhance peptide detection for clinical mass spectrometry.Secreted proteins as a fundamental source for biomarker discovery.Recent advances in protein profiling of tissues and tissue fluids.The cancer secretome: a reservoir of biomarkersIdentification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer.In vivo tumor secretion probing via ultrafiltration and tissue chamber: implication for anti-cancer drugs targeting secretome.Proteomics identification of cyclophilin a as a potential prognostic factor and therapeutic target in endometrial carcinomaPerspective: proteomic approach to detect biomarkers of human growth hormone.Cyclophilin A was revealed as a candidate marker for human oral submucous fibrosis by proteomic analysis.Poly(I:C) treatment influences the expression of calreticulin and profilin-1 in a human HNSCC cell line: a proteomic study.Comparison of alternative extraction methods for secretome profiling in human hepatocellular carcinoma cells.Cyclophilin A release as a biomarker of necrotic cell death.Microfiltration sampling in rats and in cows: toward a portable device for continuous glucocorticoid hormone sampling.Thymosin β4 is rapidly internalized by cells and does not induce intracellular Ca2+ elevation.Gaining insights into cancer biology through exploration of the cancer secretome using proteomic and bioinformatic tools.Innovative methodology for the identification of soluble biomarkers in fresh tissues.Characterization of the Tumor Secretome from Tumor Interstitial Fluid (TIF).
P2860
Q28297398-317BBEA6-85CF-4017-9578-66BC5E46A512Q33284350-95CA6D5C-740E-4B5B-B3F4-ADBFFF71D103Q33879157-8AE37F96-8C4A-4AC7-9E03-D0866E543AC7Q33973509-D5805CD8-E3B1-4D1A-A2C9-833CCED3BD26Q33989435-49FE6A12-7C4C-4852-9B50-38127444C958Q34060641-4C5891D1-24E2-4714-9D06-CC361EA093BDQ34759911-4BC35E34-5855-4CAC-A6C6-E65A1AB3E6CEQ34759942-40C60E89-76E2-4D09-B056-B247B1F933B0Q35646453-FEDBB7EB-AA56-46A0-8ABF-FACE824697C1Q35878733-33D9EB2B-77F2-4265-A942-982DC9D1F380Q36334168-2FEB4658-4D8B-4B80-8E2A-ACC4733D92E7Q36452973-F6622247-324E-40D3-B642-D8E804D238D8Q36913050-4722301F-09DB-4A7B-B185-03D6D86F2F4DQ36926612-F4F0FC72-A207-4DB1-8CEC-C3B17F630393Q36976473-9EE0A6CF-9D36-4681-83B2-D07F664C62DCQ37090386-A27346E5-195C-40DC-9384-5C1151C3D07AQ37113899-ECB59E05-1687-4A15-A9CC-A6A573D329F8Q37384139-42B795D4-31B6-47BE-9D2A-3BC4E7E5F89DQ38616058-4F071761-F065-442F-B855-FCD4A5F31342Q39380343-5032A83A-E0E6-4426-A11D-A2E5776A5F67Q39604837-38187499-2751-45DC-A8B8-500F4FBFB2B1Q39646948-1FA9A128-B709-4BA4-BEDA-F8E59EB46212Q43185004-938E86B9-312E-491C-9D40-3B88910F4231Q43930449-5CD88622-86F8-45B3-9262-EEBC04A5C897Q47716837-5D5320E7-3BD1-417C-BDB6-E5687DBC22D3Q51734150-291DA95F-7DE7-456A-A2DF-A65E342F32B0Q53022294-977E67AF-FF33-4488-8B65-EF4EB24B8F0F
P2860
Mass spectrometric proteomics profiles of in vivo tumor secretomes: capillary ultrafiltration sampling of regressive tumor masses.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Mass spectrometric proteomics ...... ng of regressive tumor masses.
@ast
Mass spectrometric proteomics ...... ng of regressive tumor masses.
@en
Mass spectrometric proteomics ...... ng of regressive tumor masses.
@nl
type
label
Mass spectrometric proteomics ...... ng of regressive tumor masses.
@ast
Mass spectrometric proteomics ...... ng of regressive tumor masses.
@en
Mass spectrometric proteomics ...... ng of regressive tumor masses.
@nl
prefLabel
Mass spectrometric proteomics ...... ng of regressive tumor masses.
@ast
Mass spectrometric proteomics ...... ng of regressive tumor masses.
@en
Mass spectrometric proteomics ...... ng of regressive tumor masses.
@nl
P2093
P356
P1433
P1476
Mass spectrometric proteomics ...... ng of regressive tumor masses.
@en
P2093
Chun-Ming Huang
Craig A Elmets
Honnavara N Ananthaswamy
Mikako Kawai
Stephen Barnes
Yuliang Ma
P304
P356
10.1002/PMIC.200600287
P577
2006-11-01T00:00:00Z